Table 2 Characteristics of the participants
Characteristics | Total (n = 3015) |
|---|---|
Age, (years) [median (IQR)] | 49 (0.7–90) |
Male gender [n/total (%)] | 2258/3015 (74.9) |
ART treatment failure [n/total (%)] | 1904/3015 (61.3) |
Drug resistance rate of ART treatment failure [n/total (%)] | 1297/3015 (43.1) |
Subtype [n/total (%)] | |
Non-B | 2938/3015 (97.4) |
B | 77/3015 (2.6) |
Distribution of non-B subtypes [n/total (%)] | |
CRF07_BC | 1217/3015 (40.4) |
CRF01_AE | 816/3015 (27.1) |
CRF08_BC | 290/3015 (9.6) |
C | 89/3015 (2.9) |
C + B | 373/3015 (12.3) |
B + CRF01_AE | 23/3015 (0.7) |
CRF55-01B | 59/3015 (1.95) |
CRF52-01B | 2/3015 (0.1) |
CRF57-BC | 4/3015 (0.1) |
A | 47/3015 (1.6) |
CRF64_BC | 8/3015 (0.3) |
CRF67-01B | 2/3015 (0.1) |
CRF59-01B | 2/3015 (0.1) |
CRF15-01B | 1/3015 (0.03) |
CRF62-BC | 2/3015 (0.1) |
CRF85-BC | 2/3015 (0.1) |
D | 1/3015 (0.03) |